Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium

The National Institute on Aging (NIA), with other members of the NIH Palliative Care Research Working Group, intends to publish a Notice of Funding Opportunity (NOFO) to invite applications proposing research on palliative care across the lifespan for persons with serious illnesses and/or their caregivers relevant to the missions of participating NIH Institutes, Centers, and Offices (ICOs), including projects focused on characterizing or mitigating disparities in palliative care access, quality, and use. Applications may propose palliative care efficacy, effectiveness, and/or implementation and dissemination clinical trials in alignment with the NIH Stage Model. Applications may also propose non-clinical trial palliative care research, such as health services research, natural experiments, health or behavioral economics, or observational studies. Awardees will become members of the research community facilitated by the NIH-funded Consortium for Palliative Care Research Across the Lifespan. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

The major elements in evaluating proposals include assessments of: the scientific merit and general significance of the proposed study and its objectives; the technical adequacy of the experimental design and approach; the competency of the proposed investigator or group to successfully pursue the project; the adequacy of the available and proposed facilities and resources; the necessity of the budget components requested in relation to the proposed project; and the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed...

This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.

Not Applicable.